IMUC
vs
CYTH
IMUC
CYTH
Over the past 12 months, IMUC has outperformed CYTH, delivering a return of +6% compared to the CYTH's 0% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
IMUC
CYTH
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
ImmunoCellular Therapeutics Ltd
OTC:IMUC
|
0.14
USD
|
|||||
|
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
99
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
IMUC, CYTH
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
ImmunoCellular Therapeutics Ltd
Revenue
|
|||||||||||
|
Cyclo Therapeutics Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
IMUC, CYTH
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
ImmunoCellular Therapeutics Ltd
OTC:IMUC
|
|||||||||
|
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
ImmunoCellular Therapeutics Ltd | ||||
|
Cyclo Therapeutics Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
ImmunoCellular Therapeutics Ltd | ||||
|
Cyclo Therapeutics Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
ImmunoCellular Therapeutics Ltd | ||||
|
Cyclo Therapeutics Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
ImmunoCellular Therapeutics Ltd | ||||
|
Cyclo Therapeutics Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
ImmunoCellular Therapeutics Ltd | ||||
|
Cyclo Therapeutics Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
ImmunoCellular Therapeutics Ltd | ||||
|
Cyclo Therapeutics Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
ImmunoCellular Therapeutics Ltd | ||||
|
Cyclo Therapeutics Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
ImmunoCellular Therapeutics Ltd | ||||
|
Cyclo Therapeutics Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
IMUC, CYTH
Performance Gap
IMUC, CYTH
Performance By Year
IMUC, CYTH
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| US |
S
|
Seagen Inc
F:SGT
|